Axcella Health Inc.
NASDAQ:AXLA
4.58 (USD) • At close September 17, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 56.984 | 43.135 | 37.039 | 41.658 | 25.486 | 22.916 |
| General & Administrative Expenses
| 15.815 | 18.711 | 16.797 | 15.781 | 8.41 | 6.005 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 15.815 | 18.711 | 16.797 | 15.781 | 8.41 | 6.005 |
| Other Expenses
| -0.08 | -0.004 | 0.01 | 0.034 | 0 | 0 |
| Operating Expenses
| 72.799 | 61.846 | 53.836 | 57.439 | 33.896 | 28.921 |
| Operating Income
| -76.988 | -61.846 | -53.836 | -57.439 | -33.896 | -28.921 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -4.198 | -2.782 | -2.691 | -1.598 | -0.014 | 0.081 |
| Income Before Tax
| -81.186 | -64.628 | -56.527 | -59.037 | -36.069 | -30.94 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 1.177 | 2.49 | 2.282 | 0.936 | -2.173 | 2.019 |
| Net Income
| -82.363 | -67.118 | -58.809 | -59.973 | -36.069 | -30.94 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -1.52 | -1.76 | -1.85 | -3.61 | -2.18 | -1.87 |
| EPS Diluted
| -1.52 | -1.76 | -1.85 | -3.61 | -2.18 | -1.87 |
| EBITDA
| -67.009 | -61.846 | -53.836 | -57.388 | -32.811 | -27.613 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 |